New
Vitiligo session at CILAD
Meet us at CILAD* conference in Madrid tomorrow, July 1st at 12 noon, for the discussion of the recent advances in treatment of pigmentary disorders and vitiligo.
Speakers:
- Dr. Gabriel Serrano Sanmiguel MD, PhD, Dermatólogo y fundador de Sesderma Laboratorios
- Dra. Eva Álvarez Roca MD, Asesor médico Sesderma-Mediderma
- Sr. D. Yan Valle, Director ejecutivo Vitiligo Research Fundation. Profesor Asociado de Marconi University
UPDATE: Madrid, Spain is the host not only for NATO summit today, but also a major congress for dermatologists and cosmetologists. Presented the Vitiligo Patient Journey Map to the overcrowded auditorium at Sesderma session. Beginning to change patient/doctor relationship in a life-long diseases like vitiligo. As the Chinese proverb goes, " A thousand miles journey begins with the first step."
* CONCRESO IBERO LATINO-AMERICANO DE DERMATOLOGÍA
FAQOther Questions
- Does halo nevi affect vitiligo development?
Halo nevi (also known as Sutton's nevi) are characterized by a mole that's surrounded by a ring of depigmented or lighter skin. While both halo nevi and vitiligo involve the des...
- Can Ayurveda help with vitiligo?
Ayurveda, the ancient Indian system of holistic medicine, focuses on balancing body energies (Doshas) and improving digestion. While it offers a valuable perspective on "whole-b...
- Shall I take vitamin D for my vitiligo?
Vitamin D plays a central role in the prevention of different inflammatory and chronic diseases. Consuming 1,000–4,000 IU (25–100 mcg) of vitamin D3 daily should be ideal for mo...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.